Ocumension Therapeutics

Ocumension Therapeuticsverified

1477.HK

Price:

$8.3

Market Cap:

$6.06B

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. As of December 31, 2021, the company had 20 drug assets in its portfolio. Ocumension Therapeutics was founded in 2017 and is headquartered in Suzhou, the People's Republic of C...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

HKSE

Ticker

1477.HK

The ROE as of December 2025 (TTM) for Ocumension Therapeutics (1477.HK) is -6.71%

According to Ocumension Therapeutics’s latest financial reports and current stock price. The company's current ROE is -6.71%. This represents a change of 48.69% compared to the average of -4.51% of the last 4 quarters.

Ocumension Therapeutics (1477.HK) Historical ROE (quarterly & annually)

How has 1477.HK ROE performed in the past?

The mean historical ROE of Ocumension Therapeutics over the last ten years is -6.45%. The current -6.71% ROE has changed 4.12% with respect to the historical average. Over the past ten years (40 quarters), 1477.HK's ROE was at its highest in in the December 2019 quarter at 51.94%. The ROE was at its lowest in in the December 2020 quarter at -20.90%.

Quarterly (TTM)
Annual

Average

-6.45%

Median

-8.36%

Minimum

-90.21%

Maximum

62.92%

Ocumension Therapeutics (1477.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Ocumension Therapeutics ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 148.87%

Maximum Annual ROE = 62.92%

Minimum Annual Increase = -243.36%

Minimum Annual ROE = -90.21%

Quarterly (TTM)
Annual
YearROEChange
2024-7.11%-45.34%
2023-13.01%-11.21%
2022-14.65%75.12%
2021-8.36%-90.73%
2020-90.21%-243.36%
201962.92%148.87%

Ocumension Therapeutics (1477.HK) Average ROE

How has 1477.HK ROE performed in the past?

The current ROE of Ocumension Therapeutics (1477.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-11.59%

5-year avg

-26.67%

10-year avg

-6.45%

Ocumension Therapeutics (1477.HK) ROE vs. Peers

How is 1477.HK’s ROE compared to its peers?

Ocumension Therapeutics’s ROE is greater than Qyuns Therapeutics Co., Ltd. (-84.24%), greater than CK Life Sciences Int'l., (Holdings) Inc. (-7.77%), greater than Jinxin Fertility Group Limited (-9.73%), greater than Jacobio Pharmaceuticals Group Co., Ltd. (-5.10%), greater than CStone Pharmaceuticals (-71.29%), greater than AIM Vaccine Co., Ltd. (-8.07%), less than AK Medical Holdings Limited (11.00%), less than Gushengtang Holdings Limited (14.79%), less than MicroPort NeuroTech Limited (11.84%), less than China Shineway Pharmaceutical Group Limited (10.84%),

Build a custom stock screener for Ocumension Therapeutics (1477.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocumension Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocumension Therapeutics (1477.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocumension Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ocumension Therapeutics's ROE?

How is the ROE calculated for Ocumension Therapeutics (1477.HK)?

What is the highest ROE for Ocumension Therapeutics (1477.HK)?

What is the 3-year average ROE for Ocumension Therapeutics (1477.HK)?

What is the 5-year average ROE for Ocumension Therapeutics (1477.HK)?

How does the current ROE for Ocumension Therapeutics (1477.HK) compare to its historical average?